Related Experiment Video
Updated: Mar 12, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice
Alba Granados-Jaén1, Maria Angulo-Ibáñez1, Xavier Rovira-Clavé1
1Celltec-UB, Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain.
Abstract:
Ataxia-telangiectasia mutated (ATM) is a cell cycle checkpoint kinase that upon activation by DNA damage leads to cell cycle arrest and DNA repair or apoptosis. The absence of Atm or the occurrence of loss-of-function mutations in Atm predisposes to tumorigenesis. MAPK7 has been implicated in numerous types of cancer with pro-survival and pro-growth roles in tumor cells, but its functional relation with tumor suppressors is not clear. In this study, we show that absence of MAPK7 delays death due to spontaneous tumor development in Atm-/- mice. Compared with Atm-/- thymocytes, Mapk7-/-Atm-/- thymocytes exhibited an improved response to DNA damage (increased phosphorylation of H2AX) and a restored apoptotic response after treatment of mice with ionizing radiation. These findings define an antagonistic function of ATM and MAPK7 in the thymocyte response to DNA damage, and suggest that the lack of MAPK7 inhibits thymic lymphoma growth in Atm-/- mice by partially restoring the DNA damage response in thymocytes.
Insights
The absence of MAPK7 delays tumor development in mice lacking ATM, a key DNA damage response protein. This suggests MAPK7 inhibition could partially restore DNA repair and apoptosis, hindering thymic lymphoma growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Ataxia-telangiectasia mutated (ATM) is a crucial kinase regulating cell cycle arrest and DNA repair following DNA damage.
- Loss-of-function mutations in ATM are linked to increased tumorigenesis.
- Mitogen-activated protein kinase 7 (MAPK7) is implicated in cancer, often promoting cell survival and growth, but its interaction with tumor suppressors like ATM is unclear.
Purpose of the Study:
- To investigate the functional relationship between ATM and MAPK7 in the context of DNA damage response and tumorigenesis.
- To determine if MAPK7 influences tumor development in mice deficient in ATM.
- To elucidate the impact of MAPK7 absence on thymocyte response to DNA damage and ionizing radiation.
Main Methods:
- Utilized Atm-/- mice to study spontaneous tumor development.
- Compared DNA damage response in Atm-/- and Mapk7-/-Atm-/- thymocytes.
- Assessed DNA damage markers (e.g., phosphorylation of H2AX) and apoptotic responses after ionizing radiation exposure.
Main Results:
- Absence of MAPK7 significantly delayed death from spontaneous tumors in Atm-/- mice.
- Mapk7-/-Atm-/- thymocytes showed enhanced DNA damage response, indicated by increased H2AX phosphorylation.
- These thymocytes also exhibited a restored apoptotic response to ionizing radiation compared to Atm-/- controls.
Conclusions:
- ATM and MAPK7 play antagonistic roles in the DNA damage response within thymocytes.
- Lack of MAPK7 can partially restore the DNA damage response in Atm-deficient thymocytes.
- Inhibiting MAPK7 may represent a therapeutic strategy to impede thymic lymphoma growth in ATM-deficient cancers.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
In-vitro Mutagenesis
MAPK Signaling Cascades
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

